tralokinumabdupilumabNumeric Rating ScaleDermatology Life Quality IndexAtopic dermatitisAD
…to pruritus and sleep outcomes compared with those treated with tralokinumab.Conflict of Interest No conflict of interest…
4articles mentioning drugs
15drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: tralokinumab ×
tralokinumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning tralokinumab
4 articles · page 1 of 1baricitinibabrocitinibdupilumablebrikizumabtralokinumabupadacitinib
…numab 300 mg biweekly; and -44.15% (95% CI -50.44 to -37.86) vs baricitinib 2 mg diary. Statistically significant differences were found be…
pirfenidonenintedanibmycophenolate mofetiltreprostiniltocilizumab
…ow (see section on Current treatments). The antifibrotic drugs, pirfenidone and nintedanib, are established treatments for idiopathic pulmo…
BaricitinibDupilumabTralokinumababrocitinibLebrikizumabupadacitinibEczema Area and Severity IndexNumeric Rating ScaleAtopic dermatitissecondary-level hospital+1 more
…12 (10–60) 4.5 (0–80) 7.5 (0–10) 0 (0–10) 8.5 (3–10) 3.5 (0–10) Baricitinib 22 (21–40) 1 (0–18) 16 (5–40) 1 (0–10) 6 (0–1) 0 (0–1) 8 (0–5) …